Perfusion-CT assessment of blood-brain barrier permeability in patients with aneurysmal subarachnoid hemorrhage

Journal of Neuroradiology

Volumn 39, Issue 5, 2012, Pages 317-325

  Kishore, Sirish ^a   Ko, Nerissa ^c   Soares, Bruno P ^a   Higashida, Randall T ^a   Tong, Elizabeth ^a   Bhogal, Sumail ^a   Bredno, Joerg ^a,d   Cheng, Su Chun ^c   Wintermark, Max ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d PHILIPS HEALTHCARE   (United States)

Author keywords

Blood brain barrier; Endothelial dysfunction; Perfusion CT; Stroke; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD BRAIN BARRIER; BLOOD BRAIN BARRIER PERMEABILITY; BRAIN BLOOD VOLUME; BRAIN VASOSPASM; COMPUTER ASSISTED TOMOGRAPHY; DIGITAL SUBTRACTION ANGIOGRAPHY; DISEASE SEVERITY; FEMALE; HUMAN; HYDROCEPHALUS; MAJOR CLINICAL STUDY; MALE; MEAN TRANSIT TIME; NEUROIMAGING; PERFUSION CT; PHYSICAL PARAMETERS; SUBARACHNOID HEMORRHAGE;

ADULT; AGED; AGED, 80 AND OVER; BLOOD-BRAIN BARRIER; CEREBRAL ANGIOGRAPHY; FEMALE; HUMANS; IODINE; MALE; MIDDLE AGED; PERFUSION IMAGING; PERMEABILITY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUBARACHNOID HEMORRHAGE; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84870654408     PISSN: 01509861     EISSN: 17730406     Source Type: Journal    
DOI: 10.1016/j.neurad.2011.11.004     Document Type: Article

References (40)

1. Hop J.W., Rinkel G.J., Algra A. Case fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke 1997, 28:660-664.
2. Stegmayr B., Eriksson M., Asplund K. Declining mortality from subarachnoid hemorrhage: changes in incidence and case fatality from 1985 through 2000. Stroke 2004, 35:2059-2063.
3. van Gijn J., Rinkel G.J.E. Subarachnoid hemorrhage: diagnosis, causes, and management. Brain 2001, 124:249-278.
4. Findlay J.M., Deagle G.M. Causes of morbidity and mortality following intracranial aneurysm rupture. Can J Neurol Sci 1998, 25:209-215.
5. Cessarini K.G., Hardemark H.G., Persson L. Improved survival after aneurysmal subarachnoid hemorrhage: review of case management during a 12-year period. J Neurosurg 1999, 90:664-672.
6. Tseng M.Y., Hutchinson P.J., Czosnyka M. Effects of acute pravastatin treatment on intensity of rescue therapy, length of inpatient stay, and 6-month outcome in patients after aneurysmal subarachnoid hemorrhage. Stroke 2007, 38(5):1545-1550.
7. Vergouwen M.D., Meijers J.C., Geskus R.B. Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial. J Cereb Blood Flow Metab 2009, 29(8):1444-1453.
8. Haley E.C., Kassell N.F., Torner J.C. A randomized trial of nicardipine in subarachnoid hemorrhage: angiographic and transcranial Doppler ultrasound results. A report of the Cooperative Aneurysm Study. J Neurosurg 1993, 78(4):548-553.
9. Macdonald R.L., Kassell N.F. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke 2008, 39(11):3015-3021. CONSCIOUS-1 Investigators.
10. Cahill J., Calvert J.W., Zhang J.H. Mechanisms of early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab 2006, 26(11):1341-1353.
11. Doczi T. The pathogenetic and prognostic significance of blood-brain barrier damage at the acute stage of aneurysmal subarachnoid haemorrhage. Clinical and experimental studies. Acta Neurochir (Wien) 1985, 77:110-132.
12. Germanò A., d'Avella D., Imperatore C. Time-course of blood-brain barrier permeability changes after experimental subarachnoid haemorrhage. Acta Neurochir (Wien) 2000, 142:575-581.
13. Dankbaar J.W., Hom J., Schneider T. Accuracy and anatomical coverage of perfusion ct assessment of the blood-brain barrier permeability: one bolus versus two boluses. Cerebrovasc Dis 2008, 26:600-605.
14. Wintermark M., Maeder P., Thiran J.P., Schnyder P., Meuli R. Quantitative assessment of regional cerebral blood flows by perfusion CT studies at low injection rates: a critical review of the underlying theoretical models. Eur Radiol 2001, 11:1220-1230.
15. Axel L. Tissue mean transit time from dynamic computed tomography by a simple deconvolution technique. Invest Radiol 1983, 18:94-99.
16. Minhas P., Menon, David K., Smielewski P. Positron emission tomographic cerebral perfusion disturbances and transcranial doppler findings among patients with neurological deterioration after subarachnoid hemorrhage. Neurosurgery 2003, 52:1017-1024.
17. Prokop M., Waaijer A., Kreuzer S. CT angiography of the carotid arteries. JBR-BTR 2004, 87:23-29.
18. Wintermark M., Uske A., Chalaron M. Multislice computerized tomography angiography in the evaluation of intracranial aneurysms: a comparison with intraarterial digital subtraction angiography. J Neurosurg 2003, 98:828-836.
19. Patlak C.S., Blasberg R.G. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data: generalizations. J Cereb Blood Flow Metab 1985, 5:584-590.
20. Patlak C.S., Blasberg R.G., Fenstermacher J.D. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983, 3:1-7.
21. Kassel N.F., Peerless S.J., Durward Q.J., Beck D.W., Drake C.G., Adams H.P. Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery 1982, 11:337-343.
22. Origitano T.C., Wascher T.M., Reichmann H., Anderson D.E. Sustained increased cerebral blood flow with prophylactic hypertensive hypervolemic hemodilution (" triple-H" therapy) after subarachnoid hemorrhage. Neurosurgery 1990, 27:729-740.
23. Pickard J.D., Murray G.D., Illingworth R., Shaw M.D.M., Teasdale G.M., Foy P.M., et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid hemorrhage: British aneurysm nimodipine trial. Br Med J 1989, 298:636-642.
24. Pickard J.D., Murray G.D., Illingworth R., Shaw M.D., Teasdale G.M., Foy P.M., et al. Oral nimodipine and cerebral ischemia following subarachnoid haemorrhage. Brit Clin Pract 1990, 44(2):66-67.
25. Hansen-Schwartz J., Vajkoczy P., Macdonald R.L. Cerebral vasospasm: looking beyond vasoconstriction. Trends in Pharmaceutical. Sciences 2007, 28(6):252-256.
26. Koźniewska E., Michalik R., Rafałowska J. Mechanisms of vascular dysfunction after subarachnoid hemorrhage. J Physiol Pharmacol 2006, 57(Suppl 11):145-160.
27. Pearl J.D., Macdonald R.L. Vasospasm after aneurysmal subarachnoid hemorrhage: need for further study. Acta Neurochir Suppl 2008, 105:207-210.
28. Claassen J., Carhuapoma R., Kreiter K.T. Global cerebral edema after subarachnoid hemorrhage: frequency, predictors, and impact on outcome. Stroke 2002, 33(5):1225-1232.
29. Schöller K., Trinkl A., Klopotowski M. Characterization of microvascular basal lamina damage and blood-brain barrier dysfunction following subarachnoid hemorrhage in rats. Brain Res 2007, 20(1142):237-246.
30. Mayhan W.G. Nitric oxide donor-induced increase in permeability of the blood-brain barrier. Brain Res 2000, 866(1-2):101-108.
31. Sehba F.A., Friedrich V., Makonnen G. Acute cerebral vascular injury after subarachnoid hemorrhage and its prevention by administration of a nitric oxide donor. J Neurosurg 2007, 106(2):321-329.
32. Provencio J.J., Vora N. Subarachnoid hemorrhage and inflammation: bench to bedside and back. Semin Neurol 2005, 25(4):435-444.
33. Argaw A.T., Gurfein B.T., Zhang Y VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown. Proc Natl Acad Sci U S A 2009, 106(6):1977-1982.
34. Yang Y., Estrada E.Y., Thompson J.F. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab 2007, 27(4):697-709.
35. Gursoy-Ozdemir Y., Qiu J., Matsuoka N. Cortical spreading depression activates and upregulates MMP-9. J Clin Invest 2004, 113(10):1447-1455.
36. Abraham D., Dashwood M Endothelin - role in vascular disease. Rheumatology (Oxford) 2008, 47(Suppl 5):v23-v24.
37. Mohácsi A., Magyar J., Tamás B. Effects of endothelins on cardiac and vascular cells: new therapeutic target for the future?. Curr Vasc Pharmacol 2004, 2(1):53-63.
38. Leung J.W., Chung S.S., Chung S.K. Endothelial endothelin-1 over-expression using receptor tyrosine kinase tie-1 promoter leads to more severe vascular permeability and blood brain barrier breakdown after transient middle cerebral artery occlusion. Brain Res 2009, 1266:121-129.
39. Narushima I., Kita T., Kubo K. Highly enhanced permeability of blood-brain barrier induced by repeated administration of endothelin-1 in dogs and rats. Pharmacol Toxicol 2003, 92(1):21-26.
40. Samuels O.B., Joseph G.J., Lynn M.J., Smith H.A., Chimowitz M.I. A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol 2000, 21:643-646.